Support for anti-LAG-3 and APC-activator combos | Prima BioMed
If you read through this, in relation to GSK28311781 you will see a milestone projection
payment for IMP731......In this report Edison are projecting a milestone payment of $6M
upon PH1 completion....This report, October 2017 is saying trial completion date is Aug 2018
put back from June 2018, thus milestone projection payment delayed from 2018 to 2019.....
However the last clinical trial update reveals Trial will now complete March 14 2018, that's
4 days time.....Trial end has been brought forward so theoretically that should bring milestone
forward to this year again......Where the $6M comes from I don't know but remember Immutep
formerly Prima biomed is a client of Edison..
Can post trial update if anyone wants it....
Add to My Watchlist
What is My Watchlist?
